HMGB1 and autoimmune disease: The best characterized and clinically relevant DAMP include high-mobility group box 1 (HMGB1), S100 proteins S100A8/A9/A12, heat shock proteins HSP60 and HSP70, β-defensins, and the cathelicidin LL-37, turning them into attractive therapeutic targets of chronic inflammatory and autoimmune diseases (31).